Sigma Launches Sigma Life Science



Loading...

By Bio-IT World Staff

March 8, 2010 | Last week Sigma-Aldrich introduced Sigma Life Science, a brand and website to emphasize the company’s current focus on biology. The website, www.wherebiobegins.com, will be home to Sigma’s biology-focused technologies and products.

The Sigma Life Science mission is expected to enable researchers to unravel the complex biomolecular interactions within cells, tissues, organs and organisms. The new brand and website are expected to generate awareness of Sigma Life Science's strengths in providing products and technologies that are intended to facilitate scientists' understanding of how diseases develop and how molecules function.
 
“The Where Bio Begins website offers a content-rich environment that encourages collaboration and direct interaction with our peers and customers in the research field,” David Smoller, president of Sigma-Aldrich's Research Biotech business unit told Bio-IT World. “We are creating a destination place for scientists to access deep biological information and innovative products essential to their research."

Sigma-Aldrich has over $750 million worth of products in its portfolio including the world's largest custom oligonucleotide service, the award-winning CompoZr Zinc Finger Nucleases (ZFN) gene editing technology (see, Zinc Finger Techniques Could Be Gene Therapy Breakthrough), and more than 25,000 monoclonal and polyclonal antibodies. All of these technologies are accessible through the 'Your Favorite Gene powered by Ingenuity' ( http://sigma.com/yfg) search engine—a dynamic, web-based biological search tool that delivers comprehensive gene-based content to model and evaluate experiments in the context of previously published scientific literature.

To support the 'Where Bio Begins' launch, eight information portals have been specifically tailored to serve the biology community. Themed around the company's core biological capabilities in targeted genome editing (bioediting), transgenics (SAGE Labs), functional genomics (biosilencing), stem cell research and epigenetics (bioreprogramming), molecular biology (biomapping), biomolecules, oligonucleotides/custom products (bionucleics), customer education and training programs (biouniversity) and bioinformatic resource (Your Favorite Gene) these sites can be accessed at www.wherebiobegins.com.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

oracle20723
The Role of Analytics in Transforming Healthcare
Sponsored by Oracle

Sharing many of the data challenges and opportunities faced by Healthcare, the Life Sciences industry remains focused on delivering new, innovative therapies and solutions to patients in a cost effective, timely and safe way. With spiraling R&D costs, new methods such as adaptive trials, and never ending need for deep pharmacovigilance, the Life Sciences companies that effectively use analytics to explore, monitor and optimize their business will rapidly become the new leaders.

Oracle’s strategy—built upon Enterprise Health Analytics and Health Data Warehouse Foundation—provides a powerful, practical, and extensible approach to delivering the IT analytics infrastructure required to confront the worldwide healthcare challenge.



pegasystems
BPM-Based Case Management Approach to Optimizing Clinical Trial Efficiency
Sponsored by Pegasystems

Business Process Management (BPM) software offers liberation in the planning and management of clinical trials today. SmartBPM provides the components for automating critical clinical trial processes ranging from protocol development and patient enrollment to site management and investigator payments. Advantages are:

  • Potentially stunning return on investment at multiple levels.
  • A 500%, or better, increase in application development time by directly executing business requirements
  • Improved customer retention
  • A 50% possible reduction in training time

Discovered is opportunity to enhance relationships with investigators, subjects, and regulators while bringing momentum to a technology-impaired study startup phase. Learn more about SmartBPM in this complimentary white paper.



Cmed paper
Next-gen Cloud-based eClinical
Sponsored by Cmed Technology

New technologies are available to leverage Cloud Computing in  managing clinical trial data. This paper discusses a next generation eClinical
platform that:

  • Speeds trial set up
  • Accommodates changes with zero downtime
  • Integrates effectively with other clinical trial technology systems

It is offered with either software-as-a-service (SaaS), or turnkey infrastructure options in which the user organization operates their own cloud using their IT teams, within their data centers. Read this paper to learn and decide how best to leverage cloud computing’s many strengths for your organization’s  particular needs.



Job Openings

mskc logo
Software Engineer – Computational Biology Center

Memorial Sloan-Kettering Cancer Center seeks an Engineer to design and develop complex data analysis systems in support of cancer genomics research projects at the Computational Biology Center. Qualified candidate will have a BA, 5+ years of software development experience and expert knowledge of Java, SQL, and HTML.

Apply: www.mskcciscareers.org.  Equal opportunity and affirmative action employer.

Web Symposia
Loading...

Bio-IT World proudly presents the Bio-IT World Web Symposia Series covering a broad array of topics within the life sciences and drug development enterprise.

Leveraging BPM to Increase Efficiencies in Clinical Trial Case Management
August 3, 2010 | 1:00 – 2:30 p.m. EST
Sponsored by: Pegasystems
Program Details | Register Here 

 


Loading...

For reprints and/or copyright permission, please contact The YGS Group, 3650 West Market Street, York, PA;

(717) 505-9701 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.